COMORBIDITY OF ROSACEA AND VARIOUS PATHOLOGICAL CONDITIONS AMONG THE POPULATION OF THE COUNTRIES OF THE WORLD, ACCOUNTING FOR TREATMENT AND PREVENTIVE MEASURES
- Authors: Sadykova R.N.1, Plutnitsky A.N.1, Mingazova E.N.1,2,3
- Affiliations:
- Biomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation A. I. Burnazyan Federal Medical Biophysical Center, 123098, Moscow, Russia
- N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia
- Kazan State Medical University, 420012, Kazan, Russia
- Issue: Vol 31 (2023): NO ()
- Pages: 881-886
- Section: Articles
- URL: https://journal-nriph.ru/journal/article/view/2042
- DOI: https://doi.org/10.32687/0869-866X-2023-31-s1-881-886
- Cite item
Abstract
About the authors
R. N. Sadykova
Biomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation A. I. Burnazyan Federal Medical Biophysical Center, 123098, Moscow, Russia
A. N. Plutnitsky
Biomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation A. I. Burnazyan Federal Medical Biophysical Center, 123098, Moscow, Russia
E. N. Mingazova
Biomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation A. I. Burnazyan Federal Medical Biophysical Center, 123098, Moscow, Russia; N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia; Kazan State Medical University, 420012, Kazan, Russia
References
- Awosika O., Oussedik E. Genetic predisposition to rosacea // Dermatol. Clin. 2018. Vol. 36, N 2. P. 87—92. doi: 10.1016/j.det.2017.11.002
- Aponte J. L., Chiano M. N., Yerges-Armstrong L. M. et al. Assessment of rosacea symptom severity by genome-wide association study and expression analysis highlights immuno-inflammatory and skin pigmentation genes // Hum. Mol. Genet. 2018. Vol. 27, N 15. P. 2762—2772. doi: 10.1093/hmg/ddy184
- Liu L., Chen Y., Chen J. et al. Association between frontal fibrosing Alopecia and Rosacea: results from clinical observational studies and gene expression profiles // Front. Immunol. 2022. Vol. 13. P. 985081. doi: 10.3389/fimmu.2022.985081
- Oliveira C. M.M., Almeida L. M.C., Bonamigo R. R. et al. Consensus on the therapeutic management of rosacea — Brazilian Society of Dermatology // An. Bras. Dermatol. 2020. Vol. 9, N 5, Suppl 1. P. 53—69. doi: 10.1016/j.abd.2020.08.001
- Zhang J., Yan Y., Jiang P. et al. Association between rosacea and cardiovascular disease: A systematic review and meta-analysis // J. Cosmet. Dermatol. 2021. Vol. 20, N 9. P. 2715—2722. doi: 10.1111/jocd.13885
- Chang H. C., Huang Y. C., Lien Y. J., Chang Y. S. Association of rosacea with depression and anxiety: A systematic review and meta-analysis // J. Affect. Disord. 2022. Vol. 299. P. 239—245. doi: 10.1016/j.jad.2021.12.008
- Incel Uysal P., Akdogan N., Hayran Y. et al. Rosacea associated with increased risk of generalized anxiety disorder: a case-control study of prevalence and risk of anxiety in patients with rosacea // An. Bras. Dermatol. 2019. Vol. 94, N 6. P. 704—709. doi: 10.1016/j.abd.2019.03.002
- Tsai T. Y., Chiang Y. Y., Huang Y. C. Cardiovascular risk and comorbidities in patients with rosacea: a systematic review and meta-analysis // Acta Derm. Venereol. 2020. Vol. 100, N 17. P. adv00300. doi: 10.2340/00015555-3668
- Cho S. I., Lee H., Cho S. Risk of Skin cancer and actinic keratosis in patients with rosacea: a nationwide population-based cohort study // Acta Derm. Venereol. 2022. Vol. 102. P. adv00803. doi: 10.2340/actadv.v102.2563
- Wu Y., Li X., Chen S. et al. Inflammatory bowel disease and rosacea: a two-sample mendelian randomization study // Dermatol. Ther. 2023. Vol. 2023. doi: 10.1155/2023/1353823
- Li S., Cho E., Drucker A. M. et al. Obesity and risk for incident rosacea in US women // J. Am. Acad. Dermatol. 2017. Vol. 77, N 6. P. 1083—1087.e5. doi: 10.1016/j.jaad.2017.08.032
- Wienholtz N. K.F., Christensen C. E., Zhang D. G. et al. Clinical characteristics of combined rosacea and migraine // Front. Med. (Lausanne). 2022. Vol. 9. P. 1026447. doi: 10.3389/fmed.2022.1026447
- Akin Belli A., Alatas E. T., Kara Polat A., Akbaba G. Assessment of thyroid disorders in patients with rosacea: a large case-control study // An. Bras. Dermatol. 2021. Vol. 96, N 5. P. 539—543. doi: 10.1016/j.abd.2021.02.004
- Chung B. Y., Kim H. O., Park C. W. et al. Relationships of serum homocysteine, vitamin B12, and folic acid levels with papulopustular rosacea severity: a case-control study // Biomed. Res. Int. 2022. P. 5479626. doi: 10.1155/2022/5479626
- Forton F. M. N. The pathogenic role of demodex mites in rosacea: a potential therapeutic target already in erythematotelangiectatic rosacea // Dermatol. Ther. (Heidelb). 2020. Vol. 10, N 6. P. 1229—1253. doi: 10.1007/s13555-020-00458-9
- Forton F. M. N. Rosacea, an infectious disease: why rosacea with papulopustules should be considered a demodicosis. A narrative review // J. Eur. Acad. Dermatol. Venereol. 2022. Vol. 36, N 7. P. 987—1002. doi: 10.1111/jdv.18049
- Nobeyama Y., Aihara Y., Asahina A. Characteristics of rosacea and similar diseases in patients wearing face masks // Skin Appendage Disord. 2022. Vol. 8, N 6. P. 462—468. doi: 10.1159/000525024
- Dall'Oglio F., Fusto C., Micali G. Intrafamilial transmission of rosacea spanning six generations: a retrospective observational study // J. Clin. Aesthet. Dermatol. 2022. Vol. 15, N 2. P. 35—39.
- Buddenkotte J., Steinhoff M. Recent advances in understanding and managing rosacea // F1000Res. 2018. Vol. 7. P. F1000 Faculty Rev-1885. doi: 10.12688/f1000research.16537.1
- Marchitto M. C., Chien A. L. Rosacea and associated comorbidities: a Google search trends analysis // J. Clin. Aesthet. Dermatol. 2020. Vol. 13, N 7. P. 36—40.
- Yang F., Zhang Q., Song D. et al. A Cross-sectional study on the relationship between rosacea severity and quality of life or psychological state // Clin. Cosmet. Investig. Dermatol. 2022. Vol. 15. P. 2807—2816. doi: 10.2147/CCID.S390921
- Kang C. N., Shah M., Tan J. Rosacea: an update in diagnosis, classification and management // Skin Therapy Lett. 2021. Vol. 26, N 4. P. 1—8.
- Nowicka D., Chilicka K., Dzieńdziora-Urbińska I., Szyguła R. Skincare in rosacea from the cosmetologist's perspective: a narrative review // J. Clin. Med. 2022. Vol. 12, N 1. P. 115. doi: 10.3390/jcm12010115
- Hu X. M., Li Z. X., Zhang D. Y. et al. Current research and clinical trends in rosacea pathogenesis // Heliyon. 2022. Vol. 8, N 10. P. e10874. doi: 10.1016/j.heliyon.2022.e10874
- Zierl S., Guertler A., Hildebrand J. A. et al. A comprehensive epidemiological study of rosacea in Germany // Eur. J. Dermatol. 2021. Vol. 31, N 6. P. 744—751. doi: 10.1684/ejd.2021.4165
- van Zuuren E. J., Arents B. W.M., van der Linden M. M.D. et al. Rosacea: new concepts in classification and treatment // Am. J. Clin. Dermatol. 2021. Vol. 22, N 4. P. 457—465. doi: 10.1007/s40257-021-00595-7
- Miyachi Y., Yamasaki K., Fujita T., Fujii C. Metronidazole gel (0.75%) in Japanese patients with rosacea: a randomized, vehicle-controlled, phase 3 study // J. Dermatol. 2022. Vol. 49, N 3. P. 330—340. doi: 10.1111/1346-8138.16254
- Del Rosso J. Q., York J. P., Bhatia N. Effective treatment of inflammatory lesions of rosacea with subantibiotic dose doxycycline irrespective of patient weight or baseline lesion count severity // J. Clin. Aesthet. Dermatol. 2022. Vol. 15, N 11. P. 69—74.
- van Zuuren E. J., Fedorowicz Z., Tan J. et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments // Br. J. Dermatol. 2019. Vol. 181, N 1. P. 65—79. doi: 10.1111/bjd.17590
- Sarkar R., Podder I., Jagadeesan S. Rosacea in skin of color: A comprehensive review // Indian J. Dermatol. Venereol. Leprol. 2020. Vol. 86, N 6. P. 611—621. doi: 10.4103/ijdvl.IJDVL_769_19
- Maliyar K., Abdulla S. J. Dermatology: how to manage rosacea in skin of colour // Drugs Context. 2022. Vol. 11. P. 2021-11-1. doi: 10.7573/dic.2021-11